‘De-extinction’ startup Colossal Biosciences makes its first acquisition: a company that clones pets
Scooping up ViaGen Pets and Equine ostensibly adds more genetic firepower to Colossal’s arsenal. Terms of the acquisition were not disclosed.
The cloning industry is contracting—ironically, perhaps.
What did you think of this news? Leave a comment below and/or share it on your social media. This way, we can inform more people about the hottest things in technology, science, innovation, and gaming!
This news was originally published in:
Original source
